You Might Also Like: Unseen Upside: Investments Beyond Their Returns
04/25/24 • -1 min
Introducing S4:E6 AI & Healthcare: The Next Frontier from Unseen Upside: Investments Beyond Their Returns.
Follow the show: Unseen Upside: Investments Beyond Their Returns
Artificial intelligence is transforming healthcare, unleashing new investment opportunities. From cancer screening to drug discovery, AI promises to augment clinical decision-making and improve care. We’ll explore the surging ecosystem of medical AI innovations, from the emerging tech landscape to practical deployment. But what are the challenges facing real-world implementation? Which applications show the most promise? Join us as we investigate how artificial intelligence can change healthcare for the better while examining what it will take to do it well.
Guests include:
- Bob Nelsen, Co-Founder and Managing Director at Arch Venture Partners
- Daphne Koller, Founder and CEO at insitro
- David Baker, Ph.D., Director at the Institute for Protein Design and Professor of Biochemistry at University of Washington
- Theresa Hajer, Partner and Managing Director of Venture Capital Research at Cambridge Associates
Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company. Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
Introducing S4:E6 AI & Healthcare: The Next Frontier from Unseen Upside: Investments Beyond Their Returns.
Follow the show: Unseen Upside: Investments Beyond Their Returns
Artificial intelligence is transforming healthcare, unleashing new investment opportunities. From cancer screening to drug discovery, AI promises to augment clinical decision-making and improve care. We’ll explore the surging ecosystem of medical AI innovations, from the emerging tech landscape to practical deployment. But what are the challenges facing real-world implementation? Which applications show the most promise? Join us as we investigate how artificial intelligence can change healthcare for the better while examining what it will take to do it well.
Guests include:
- Bob Nelsen, Co-Founder and Managing Director at Arch Venture Partners
- Daphne Koller, Founder and CEO at insitro
- David Baker, Ph.D., Director at the Institute for Protein Design and Professor of Biochemistry at University of Washington
- Theresa Hajer, Partner and Managing Director of Venture Capital Research at Cambridge Associates
Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company. Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
Previous Episode
This Month in German, Swiss, and Austrian (GSA) Startups - March 2024
Welcome to our March 2024 wrap-up with vital news from the startup and tech entrepreneurship scenes in Germany, Austria, and Switzerland in 30 minutes or less 🙂.
Our startup news is recorded with Chris in New York City and Joe in Frankfurt. Recording date is March 25th 2024 and all news not included will be in our next news to be released on April 25th 2024.
Happy Easter!Today we publish on Holy Thursday (Gründonnerstag) in Germany. Note that the Friday before and Monday after Easter are public holidays. Many people will take off around the holidays. So don’t expect your calls to be returned promptly during this time.
A Seismic Shift in the Regional Startup Scene
You are witnessing a seismic shift in the GSA startup scene with us here and today. The headlines of our startup news used to be dominated by fintech funding. Now we have more than 7 billion € investments in green startups (battery, renewable energy) vs. “only” around 150 million in fintech funding in different forms. This is surely a foretaste of what’s to come.
Our Highlights:
The European energy landscape is witnessing significant developments with key investments across sectors.
Northvolt’s Gigafactory in Northern Germany, backed by €900 million in subsidies and a €4.5 billion investment, aims to produce 1 million car batteries annually, driving electric vehicle adoption and job creation.
Enpal secured €1.1 billion in refinancing commitments, while Sunfire raised over €500 million, bolstering Europe’s green hydrogen economy.
ENVIRIA secured $200 million in capital from BlackRock, signaling confidence in the solar sector.
Solaris Bank secured €96 million in funding but faced a €6.5 million fine from BaFin, reflecting fintech regulatory challenges.
Magic gained traction with open AI’s and Tesla’s former Andrej Karpathy as investor, and Bitpanda established a €50 million VC fund for blockchain startups. However, the startup community grapples with stress, with nearly half considering quitting, underscoring the toll of rapid innovation.
Let’s talk startups: https://medium.com/startuprad-io/this-month-in-german-swiss-and-austrian-gsa-startups-march-2024-a49996ca44f9
Find All Other Channels Here
Find all options to subscribe here: https://linktr.ee/startupradio
Housekeeping & Time to Brag — Celebrating one Million Downloads in a Quarter!
1 Million confirmed downloads in Q4 2023: https://www.linkedin.com/feed/update/urn:li:activity:7176895440510955520/
Feedback
We would love to hear from YOU!!!
https://forms.gle/mLV6mVKwGwKuut8BA
The Hosts
The news are co-hosted by Jörn “Joe” Menninger, startup scout, founder, and host of Startuprad.io. And Christian “Chris' ' Fahrenbach, co-founder Startuprad.io, freelance reporter, lecturer, author and blogger . Reach out to them:
Chris on LinkedIn
Next Episode
This Month in German, Swiss, and Austrian (GSA) Startups - April 2024
Lower your Costs of ISO 27.001 and SOC 2 Compliance by up to 85% [with our Partner Vanta]
Achieving ISO 27001 or SOC 2 compliance can unlock major growth for your company and build customer trust, but this process can be time-intensive and costly. Vanta automates compliance, getting you audit-ready quickly and saving you up to 85% of associated costs. And Vanta scales with your business, helping you enter new markets. Join 7,000 global companies like Atlassian, Flo Health, and Quora that trust Vanta. Claim 20% off Vanta at vanta.com/startupradio
Interested in Working with us? Have a look here:
https://www.passionfroot.me/startupradio
Find all options to follow us and subscribe here:
https://linktr.ee/startupradio
🌟 April 2024 Startup & Tech Wrap-Up 🌟 | Germany, Austria, Switzerland | Biotech Breakthroughs, Fintech Boom & Space Innovation 🚀
In just 30 minutes, get the latest on the hottest entrepreneurship news from the heart of Europe! From groundbreaking acquisitions to futuristic ventures, here's what you need to know:
🔬 Novo Nordisk's €1.025B Biotech Splash! Discover how Novo Nordisk's landmark acquisition of Cardior Pharmaceuticals is reshaping the biotech landscape.
🚁 Volocopter's €150M Boost! Despite challenges, Volocopter gets a significant funding injection for its flying taxi vision.
💡 Zolar Shines with €100M! Learn about Zolar's massive credit line and its innovative financing options.
💰 ELEMENT Scores €50M! Explore how ELEMENT is revolutionizing InsurTech with its latest funding round.
🏦 Berlin: Fintech Capital! Berlin solidifies its status as the Fintech Capital with 160 thriving startups.
🛰️ Mynaric's Space Laser Triumph! Witness Mynaric's milestone in global space development with the CONDOR Mk3.
Don't miss out on the latest tech and entrepreneurial breakthroughs! Watch now for all the details. #entrepreneurship #technews #startupscene #startupradio
Find all links and show notes here:
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/security-sutra-cybersecurity-startups-and-venture-capital-193754/you-might-also-like-unseen-upside-investments-beyond-their-returns-51154690"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to you might also like: unseen upside: investments beyond their returns on goodpods" style="width: 225px" /> </a>
Copy